Clinical trial Recruiting at 1 site Interventional Ages 21 to 29

Brief mindfulness plus vagus nerve stimulation to lower alcohol cue reactivity in young heavy drinkers

Official title: Exploring the Feasibility and Acceptability of Brief Mindfulness Training With Vagal Nerve Stimulation for Reducing Alcohol Consumption Among Young Adults

Run by Cambridge Health Alliance · NCT07516873 · Data updated 2026-11-12

This project will test whether a one-week mindfulness program combined with either active or inactive ear-based vagus nerve stimulation can reduce alcohol cue reactivity and drinking in 21–29-year-old heavy drinkers.

More Heavy Drinking trials

Quick facts

Study typeInterventional
Ages21 Years to 29 Years
SexAll
Enrollment50 (estimated)
SponsorCambridge Health Alliance
Academic / other
Locations1 site (Malden, Massachusetts)
StatusRecruiting
StartedMarch 6, 2026
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedMay 12, 2026
Trial IDNCT07516873 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are 21–29 years old, currently living in Massachusetts, meet the trial's heavy-drinking thresholds, have sufficient English fluency, and score at least 15 on the PACS at screening.

Probably not a fit

People with a current or past DSM-5 substance use disorder, active psychosis, those taking sedative/hypnotics, opioids, anesthetics, or medications for AUD, or those living outside Massachusetts are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants complete a one-week brief mindfulness intervention and are randomized to receive active or sham respiratory-gated auricular vagal afferent nerve stimulation (RAVANS) during two in-person lab visits. The protocol collects heart rate variability during resting periods and responses to alcohol-related cues, along with self-report surveys on drinking and related symptoms. Visits include a device fit test, a drinking-related stimuli exposure task with visual cues, and follow-up surveys conducted virtually one week after the second lab visit. The trial focuses on acceptability and feasibility in a community sample recruited in Massachusetts.

Why it matters

Potential benefit: If successful, this approach could lower cue-triggered cravings, improve autonomic regulation, and help reduce alcohol use among young heavy drinkers.

How similar studies have gone: Prior pilot work with vagus nerve stimulation and with mindfulness separately has shown promise for reducing craving and improving heart rate variability, but combining a brief mindfulness program with RAVANS for alcohol cue reactivity is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Currently living in Massachusetts.
* Aged 21-29 years old.
* Consume either more than 14 standard drinks of alcohol per week OR at least 5 standard drinks in one day per week (in past 30 days).
* Have sufficient English fluency to understand procedures and questionnaires.
* Have the capacity and ability to provide informed consent.
* Scores at least 15 points on the PACS at screening. Participants who score between 10 and 14 pts will undergo additional doctoral-level review to assess eligibility.

Exclusion Criteria:

* Current or past diagnosis of a substance use disorder based on the Quick Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) Module C (Substance Use Disorders).
* Active prescription for sedative/hypnotics, opioids, or anesthetic medications.
* Active prescription for medications used to treat alcohol use disorder (AUD), e.g., naltrexone, disulfiram, acamprosate, etc.
* Active psychosis or schizophrenia-spectrum disorder diagnosis.
* Bipolar I disorder history or severe level of mania.
* Severe symptoms of PTSD.
* Acute suicidality or self-injurious behavior.
* Cognitive inability as demonstrated by the inability to complete an informed consent assessment with \>90% accuracy after 2 attempts.
* Current participation in another experimental intervention research study.
* Current daily mindfulness practice \>10 minutes per day.
* Participation in an 8-week intensive Mindfulness-Based Intervention or residential meditation retreat in past 3 years.
* Expected medical hospitalization in the next 2 months; or are currently pregnant.
* Expected incarceration in the next 2 months.
* Presence of electronic implants, such as heart pacemakers, defibrillators, or pumps.
* Presence of a cardiac rhythm disorder.
* History of seizures.
* Presence of skin disorders or malignant diseases in the area in or around the left ear.
* Lack of alcohol craving as assessed by the PACS during screening (score of \< 10 points).

Where it's running

  • Center for Mindfulness and Compassion
    Malden, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.